Workflow
This
page
is
part
of
the
Continuous
Integration
Build
of
FHIR
Specification
(v5.0.0:
R5
-
STU
).
This
is
the
current
published
version
in
it's
permanent
home
(it
will
always
(will
be
available
incorrect/inconsistent
at
this
URL).
For
a
full
list
of
available
versions,
see
times).
See
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
| Responsible Owner: Clinical Decision Support Work Group | Standards Status : Informative | Compartments : No defined compartments |
Raw XML ( canonical form + also see XML Format Specification )
Opioid CDS Recommendation 11 ECA Rule (id = "opioidcds-11")
<?xml version="1.0" encoding="UTF-8"?> <PlanDefinition xmlns="http://hl7.org/fhir"> <id value="opioidcds-11"/>display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%: Concurrently prescribing opioid medications with benzodiazepines increases the risk of harm for the patient.Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus')Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus')ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.: Clinicians should avoid prescribing opioid pain medication and benzodiazepines concurrently whenever possible.: Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH: : Checking if the trigger prescription meets the inclusion criteria for recommendation #11 workflow.<extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"> <valueCode value="cds"/> </extension> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.113883.4.642.11.2"/> </identifier> <identifier> <use value="official"/> <value value="cdc-opioid-guidance"/> </identifier> <version value="0.1.0"/> <name value="Cdcopioid11"/> <title value="CDC Opioid Prescribing Guideline Recommendation #11"/> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/> <code value="eca-rule"/> <display value="ECA Rule"/> </coding> </type> <status value="draft"/> <date value="2018-03-19"/><publisher value="HL7 International / Clinical Decision Support"/> <contact> <telecom> <system value="url"/> <value value="http://www.hl7.org/Special/committees/dss"/> </telecom> </contact> <description value="Concurrently prescribing opioid medications with benzodiazepines increases the risk of harm for the patient."/> <useContext> <code> <system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/> <code value="focus"/> <display value="Clinical Focus"/> </code> <valueCodeableConcept> <coding> <system value="http://snomed.info/sct"/> <code value="182888003"/> <display value="Medication requested (situation)"/> </coding> </valueCodeableConcept> </useContext> <useContext> <code> <system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/> <code value="focus"/> <display value="Clinical Focus"/> </code> <valueCodeableConcept> <coding> <system value="http://snomed.info/sct"/> <code value="82423001"/> <display value="Chronic pain (finding)"/> </coding> </valueCodeableConcept> </useContext> <jurisdiction> <coding> <system value="urn:iso:std:iso:3166"/> <code value="US"/> <display value="United States of America"/> </coding> </jurisdiction> <purpose value="CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care."/> <usage value="Clinicians should avoid prescribing opioid pain medication and benzodiazepines concurrently whenever possible."/> <copyright value="© CDC 2016+."/> <topic> <text value="Opioid Prescribing"/> </topic> <author> <name value="Kensaku Kawamoto, MD, PhD, MHS"/> </author> <author> <name value="Bryn Rhodes"/> </author> <author> <name value="Floyd Eisenberg, MD, MPH"/> </author> <author> <name value="Robert McClure, MD, MPH"/> </author> <relatedArtifact> <type value="documentation"/> <display value="CDC guideline for prescribing opioids for chronic pain"/> <document> <url value="https://guidelines.gov/summaries/summary/50153/cdc-guideline-for-prescribing-opioids-for-chro nic-pain---united-states-2016#420"/> </document> </relatedArtifact> <relatedArtifact> <type value="documentation"/> <display value="MME Conversion Tables"/> <document> <url value="https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf"/> </document> </relatedArtifact> <library value="http://example.org/fhir/Library/opioidcds-recommendation-11"/> <action> <extension url="http://hl7.org/fhir/StructureDefinition/cqf-strengthOfRecommendation"> <valueCodeableConcept> <coding> <system value="http://terminology.hl7.org/CodeSystem/recommendation-strength"/> <code value="strong"/> <display value="Strong"/> </coding> </valueCodeableConcept> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/cqf-qualityOfEvidence"> <valueCodeableConcept> <coding> <system value="http://terminology.hl7.org/CodeSystem/evidence-quality"/> <code value="low"/> <display value="Low quality"/> </coding> </valueCodeableConcept> </extension> <title value="Existing patient has concurrent opioid and benzodiazepine prescriptions."/> <description value="Checking if the trigger prescription meets the inclusion criteria for recommendation #11 workflow."/> <documentation> <type value="documentation"/></documentation> <trigger> <type value="named-event"/> <name value="medication-prescribe"/> </trigger> <condition> <kind value="applicability"/> <expression> <description value="Check whether the existing patient is using opioids concurrently with benzodiazepines."/><language value="text/cql-identifier"/> <expression value="Inclusion Criteria"/> </expression> </condition> <groupingBehavior value="visual-group"/> <selectionBehavior value="exactly-one"/> <dynamicValue> <path value="action.description"/> <expression><language value="text/cql-identifier"/> <expression value="Get Detail"/> </expression> </dynamicValue> <dynamicValue> <path value="action.title"/> <expression><language value="text/cql-identifier"/> <expression value="Get Summary"/> </expression> </dynamicValue> <dynamicValue> <path value="action.extension"/> <expression><language value="text/cql-identifier"/> <expression value="Get Indicator"/> </expression> </dynamicValue> <action> <description value="Will revise"/> </action> <action> <description value="Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo"/> </action> <action> <description value="N/A - see comment; snooze 3 mo"/> </action> </action> </ PlanDefinition >
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR
®©
HL7.org
2011+.
FHIR
R5
hl7.fhir.core#5.0.0
R6
hl7.fhir.core#6.0.0-ballot3
generated
on
Sun,
Mar
26,
2023
15:25+1100.
Sat,
Nov
8,
2025
03:19+0000.
Links:
Search
|
Version
History
|
Contents
|
Glossary
|
QA
|
Compare
to
R4
|
Compare
to
R4B
R5
|
Compare
to
Last
Ballot
|
|
Propose
a
change